Skip to main content
OpenTrials

Clinical trial condition

Resectable Cholangiocarcinoma

Explore clinical trials studying Resectable Cholangiocarcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Resectable Cholangiocarcinoma trial results

Completed

Gemcitabine, Cisplatin, and Nab-Paclitaxel Before Surgery in Patients With High-Risk Liver Bile Duct Cancer

NCT03579771

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +9 more
Locations
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details

Related conditions